Use of prescription opioids and other psychotropic drugs during pregnancy and their impact on the mother and developing child: protocol for a cohort study using linked administrative data from Manitoba and British Columbia, Canada

The study was approved by the University of Manitoba Human Research Ethics Board (No. HS24397 - H2020:470) and the University of British Columbia Clinical Research Ethics Board (No. H21-02262). The study will generate findings that will add to the growing body of evidence of potential short- and long-term adverse effects on children exposed to these drugs prenatally and will help to inform safe prescribing guidelines during pregnancy. Results will be published in peer-reviewed journals.

Authors

Institutions

Publication Details

Journal
BMJ Open
Published
2025-05-01
DOI
https://doi.org/10.1136/bmjopen-2024-097657
Primary Topic
Prenatal Substance Exposure Effects
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Use of prescription opioids and other psychotropic drugs during pregnancy and their impact on the mother and developing child: protocol for a cohort study using linked administrative data from Manitoba and British Columbia, Canada

Laurence Y. Katz, Chelsea Ruth, Christine Leong, Ana Hanlon‐Dearman et al.
BMJ Open
Prenatal Substance Exposure Effects
article

Use of prescription opioids and other psychotropic drugs during pregnancy and their impact on the mother and developing child: protocol for a cohort study using linked administrative data from Manitoba and British Columbia, Canada

Laurence Y. Katz, Chelsea Ruth, Christine Leong, Ana Hanlon‐Dearman, Nathan Nickel, Alan Katz, James M. Bolton, Lauren E. Kelly, Dan Château, Marni Brownell, Jennifer Enns, Lindsey Dahl, Kimberlyn McGrail, Colin R. Dormuth, Jason Kim, Matthew Dahl, Deepa Singal
article en

Abstract

The study was approved by the University of Manitoba Human Research Ethics Board (No. HS24397 - H2020:470) and the University of British Columbia Clinical Research Ethics Board (No. H21-02262). The study will generate findings that will add to the growing body of evidence of potential short- and long-term adverse effects on children exposed to these drugs prenatally and will help to inform safe prescribing guidelines during pregnancy. Results will be published in peer-reviewed journals.

BMJ OpenVol. 15(5)
Manitoba Health (CA), Australian Institute of Health and Welfare (AU), University of British Columbia (CA), University of Manitoba (CA)
Canadian Institutes of Health Research
Good health and well-being
Openalex Percentile: Top 87%
Prenatal Substance Exposure Effects
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.